We are pleased to announce that the acquisition of Avid Bioservices by GHO Capital Partners and Ampersand Capital Partners has been completed. Read the Press Release

All Resources

A Viral Vector CDMO Vision that Resonates

March 14, 2024

Building a viral vector manufacturing facility from the ground up. Members of Avid Bio’s leadership team discuss the key considerations that went into designing their viral vector manufacturing facility and how it will deliver quality viral vector process development and CGMP manufacturing.

All Resources

A Viral Vector CDMO Vision that Resonates

Sign up for Avid emails.

Follow Us:

Get the latest from Avid.

Follow Us:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content:

Please complete this form to access the content: